Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 09/13/22
End: 06/30/29
Due: 06/30/30
Phase: N/A
Priority: Normal
Start: 05/18/15
End: 03/06/18
Due: 03/06/19
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| IDH Targeted/Non- Targeted vs Non-targeted/IDH-targeted Approaches in the Treatment of Newly Diagnosed IDH Mutated AML Patients Not Candidates for Intensive Induction Therapy (I- DATA Study) | NCT05401097 | Alice Mims | user2@example.com | None | 2022-09-13 | 2029-06-30 | 2030-06-30 | - | - | 2025-07-14 |
| Selinexor and Chemotherapy in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia | NCT02299518 | Alice Mims | user2@example.com | None | 2015-05-18 | 2018-03-06 | 2019-03-06 | - | - | 2025-07-14 |